|
1
|
Hodge DR, Hurt EM and Farrar WL: The role
of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer.
41:2502–2512. 2005.
|
|
2
|
Rose-John S, Scheller J, Elson G and Jones
SA: Interleukin-6 biology is coordinated by membrane-bound and
soluble receptors: role in inflammation and cancer. J Leukoc Biol.
80:227–236. 2006.
|
|
3
|
Chavey C, Bibeau F, Gourgou-Bourgade S, et
al: Oestrogen receptor negative breast cancers exhibit high
cytokine content. Breast Cancer Res. 9:R152007.
|
|
4
|
Kozlowski L, Zakrzewska I, Tokajuk P and
Wojtukiewicz MZ: Concentration of interleukin-6 (IL-6),
interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of
breast cancer patients. Rocz Akad Med Bialymst. 48:82–84. 2003.
|
|
5
|
Bachelot T, Ray-Coquard I, Menetrier-Caux
C, Rastkha M, Duc A and Blay JY: Prognostic value of serum levels
of interleukin 6 and of serum and plasma levels of vascular
endothelial growth factor in hormone-refractory metastatic breast
cancer patients. Br J Cancer. 88:1721–1726. 2003.
|
|
6
|
Ailles LE and Weissman IL: Cancer stem
cells in solid tumors. Curr Opin Biotechnol. 18:460–466. 2007.
|
|
7
|
Rosen JM and Jordan CT: The increasing
complexity of the cancer stem cell paradigm. Science.
324:1670–1673. 2009.
|
|
8
|
Shackleton M, Quintana E, Fearon ER and
Morrison SJ: Heterogeneity in cancer: cancer stem cells versus
clonal evolution. Cell. 138:822–829. 2009.
|
|
9
|
Al-Ejeh F, Smart CE, Morrison BJ, et al:
Breast cancer stem cells: treatment resistance and therapeutic
opportunities. Carcinogenesis. 32:650–658. 2011.
|
|
10
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003.
|
|
11
|
Sullivan NJ, Sasser AK, Axel AE, et al:
Interleukin-6 induces an epithelial-mesenchymal transition
phenotype in human breast cancer cells. Oncogene. 28:2940–2947.
2009.
|
|
12
|
Morel AP, Lievre M, Thomas C, Hinkal G,
Ansieau S and Puisieux A: Generation of breast cancer stem cells
through epithelial-mesenchymal transition. PLoS One.
3:e28882008.
|
|
13
|
Mani SA, Guo W, Liao MJ, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008.
|
|
14
|
Prevo R, Deutsch E, Sampson O, et al:
Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine
inhibitor PI-103 enhances tumor radiosensitivity. Cancer Res.
68:5915–5923. 2008.
|
|
15
|
Phillips TM, McBride WH and Pajonk F: The
response of CD24(−/low)/CD44+ breast cancer-initiating
cells to radiation. J Natl Cancer Inst. 98:1777–1785. 2006.
|
|
16
|
Van Phuc P, Nhan PL, Nhung TH, et al:
Downregulation of CD44 reduces doxorubicin resistance of CD44CD24
breast cancer cells. Onco Targets Ther. 4:71–78. 2011.
|
|
17
|
Ponti D, Costa A, Zaffaroni N, et al:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005.
|
|
18
|
De Visser KE and Coussens LM: The
inflammatory tumor microenvironment and its impact on cancer
development. Contrib Microbiol. 13:118–137. 2006.
|
|
19
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001.
|
|
20
|
Li F, Tiede B, Massague J and Kang Y:
Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res.
17:3–14. 2007.
|
|
21
|
Yu F, Yao H, Zhu P, et al: let-7 regulates
self renewal and tumorigenicity of breast cancer cells. Cell.
131:1109–1123. 2007.
|
|
22
|
Hay ED: The mesenchymal cell, its role in
the embryo, and the remarkable signaling mechanisms that create it.
Dev Dyn. 233:706–720. 2005.
|
|
23
|
Thiery JP: Epithelial-mesenchymal
transitions in development and pathologies. Curr Opin Cell Biol.
15:740–746. 2003.
|
|
24
|
Dontu G, Abdallah WM, Foley JM, et al: In
vitro propagation and transcriptional profiling of human mammary
stem/progenitor cells. Genes Dev. 17:1253–1270. 2003.
|
|
25
|
Ackland ML, Newgreen DF, Fridman M, et al:
Epidermal growth factor-induced epithelio-mesenchymal transition in
human breast carcinoma cells. Lab Invest. 83:435–448. 2003.
|
|
26
|
Strutz F, Zeisberg M, Ziyadeh FN, et al:
Role of basic fibroblast growth factor-2 in epithelial-mesenchymal
transformation. Kidney Int. 61:1714–1728. 2002.
|
